CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES
Over the course of the past couple of decades, we have witnessed some significant improvements in the treatment of metastatic colorectal cancer: the emergence of novel targeted drugs and a differentiated approach to their administration, the extension of indications for surgical resection for liver...
Main Authors: | N. V. Dobrova, O. O. Gordeeva, E. V. Chernoglazova, A. A. Tryakin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2169 |
Similar Items
-
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer
by: Hélène Bellio, et al.
Published: (2021-10-01) -
Time-Tested Strategies in Modern Context: A Bibliometric Study of Chemotherapy’s Continued Importance in Colorectal Cancer Treatment
by: Helena Clar-Marmaneu, et al.
Published: (2023-09-01) -
Triple combination of irinotecan + oxaliplatin + 5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer: first experience with a new treatment regimen
by: A. D. Darenskaya, et al.
Published: (2018-05-01) -
Prognostic value of Bax expression in the primary colon tumor of patients with metastatic colorectal cancer receiving first-line treatment with a triple combination of irinotecan + oxaliplatin + long-term infusion of 5-fluorouracil
by: A. D. Darenskaya, et al.
Published: (2019-06-01) -
Chemotherapy of metastatic colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)